- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
Arotide
Metered-Dose Inhaler (MDI)
Generic Name
Salmeterol + Fluticasone Propionate
Manufacturer
Eskayef Pharmaceuticals Ltd.
Unit Price
120 metered doses: ৳ 795.00
🔹 Indications
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
🔹 Pharmacology
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Dosage & Administration
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Interaction
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Contraindications
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Side Effects
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Pregnancy & Lactation
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Precautions & Warnings
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Pediatric Usage
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
🔹 Storage Conditions
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
- Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short acting β2-agonist or
- Patients already adequately controlled on both inhaled corticosteroid and long-acting β2-agonist.
💡 Frequently Asked Questions
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sh...
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sh...
Arotide is indicated in the regular treatment of asthma where use of a combination product (long-acting β2-agonist and inhaled corticosteroid) is appropriate:
Patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled sh...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.